Venn Life Sciences' share surge after upbeat FY update

Venn Life Science's shares were up almost a fifth as it issued an upbeat update on full-year 2016, saying the 12-month period represented another of strong growth.

Sales for the period were in excess of €18m, from €11m. The business finished 2016 with a strong cash position of €3m, from €1.75m at 30 June 2016).

"The strong momentum enjoyed by the business in 2016 has continued into 2017 todate, with new business contracts signed to the value €5.7m in the first two months of the year," it said.

At 10:45 GMT, shares in AIM-quoted Venn were up 18.84% to 20.50p each.